Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954.

The therapeutic efficacy of an experimental antiviral agent, WIN 54954, was evaluated in murine myocardial infection with coxsackievirus A9 (CVA9). Eight-month-old male Swiss Webster mice were inoculated with 1.5 x 10(4) PFU of CVA9, Boston strain 13. WIN 54954, a broad-spectrum antipicornavirus age...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	See, D M, Tilles, J G
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1992
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188451/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1318683/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.2.425
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!